 Eszter Vladar
Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cilia | 19 | 2023 | 179 | 3.170 |
Why?
| | Epithelial Cells | 16 | 2023 | 1065 | 2.400 |
Why?
| | Cell Polarity | 8 | 2020 | 140 | 2.070 |
Why?
| | Cystic Fibrosis | 10 | 2023 | 1053 | 1.640 |
Why?
| | Respiratory Mucosa | 11 | 2025 | 307 | 1.510 |
Why?
| | Wnt Signaling Pathway | 4 | 2023 | 170 | 1.490 |
Why?
| | Trachea | 7 | 2020 | 220 | 1.240 |
Why?
| | Lung | 15 | 2025 | 3930 | 0.900 |
Why?
| | Airway Remodeling | 1 | 2024 | 61 | 0.870 |
Why?
| | Asthma | 8 | 2025 | 2230 | 0.830 |
Why?
| | Vaping | 1 | 2023 | 54 | 0.770 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2023 | 89 | 0.740 |
Why?
| | Organogenesis | 2 | 2019 | 56 | 0.730 |
Why?
| | Centrioles | 5 | 2018 | 41 | 0.720 |
Why?
| | Mucus | 3 | 2025 | 77 | 0.670 |
Why?
| | Rhinitis | 4 | 2023 | 152 | 0.650 |
Why?
| | Lung Diseases | 3 | 2022 | 742 | 0.640 |
Why?
| | Olfaction Disorders | 4 | 2024 | 60 | 0.620 |
Why?
| | Sinusitis | 4 | 2023 | 210 | 0.610 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 7 | 2023 | 312 | 0.600 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2018 | 39 | 0.600 |
Why?
| | Wnt Proteins | 4 | 2020 | 127 | 0.580 |
Why?
| | Geminin | 1 | 2016 | 1 | 0.520 |
Why?
| | Mice | 20 | 2025 | 16937 | 0.520 |
Why?
| | Movement | 1 | 2018 | 269 | 0.510 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 985 | 0.510 |
Why?
| | Morphogenesis | 2 | 2017 | 158 | 0.510 |
Why?
| | Xenopus Proteins | 3 | 2013 | 35 | 0.510 |
Why?
| | Animals | 27 | 2025 | 35361 | 0.460 |
Why?
| | beta Catenin | 3 | 2020 | 223 | 0.440 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2023 | 399 | 0.420 |
Why?
| | Signal Transduction | 8 | 2023 | 4925 | 0.410 |
Why?
| | Idiopathic Pulmonary Fibrosis | 3 | 2025 | 636 | 0.370 |
Why?
| | Receptors, Notch | 2 | 2023 | 84 | 0.340 |
Why?
| | Microtubules | 1 | 2012 | 263 | 0.340 |
Why?
| | Developmental Biology | 1 | 2009 | 22 | 0.320 |
Why?
| | Mucins | 3 | 2025 | 70 | 0.320 |
Why?
| | Humans | 43 | 2025 | 129650 | 0.320 |
Why?
| | Frizzled Receptors | 3 | 2020 | 23 | 0.310 |
Why?
| | Neovascularization, Pathologic | 2 | 2025 | 297 | 0.310 |
Why?
| | Enterovirus Infections | 2 | 2023 | 171 | 0.300 |
Why?
| | Stem Cells | 2 | 2023 | 577 | 0.280 |
Why?
| | Melanocytes | 2 | 2020 | 64 | 0.280 |
Why?
| | Protein Transport | 2 | 2020 | 428 | 0.280 |
Why?
| | Tumor Suppressor Proteins | 3 | 2020 | 317 | 0.260 |
Why?
| | Phosphoproteins | 1 | 2008 | 332 | 0.260 |
Why?
| | Pulmonary Alveoli | 2 | 2025 | 400 | 0.240 |
Why?
| | Smell | 2 | 2023 | 137 | 0.240 |
Why?
| | Epithelium | 2 | 2023 | 311 | 0.240 |
Why?
| | Fucosyltransferases | 1 | 2025 | 32 | 0.230 |
Why?
| | Cell Cycle Proteins | 2 | 2013 | 586 | 0.230 |
Why?
| | Capillaries | 1 | 2025 | 103 | 0.230 |
Why?
| | Bronchial Hyperreactivity | 1 | 2025 | 105 | 0.230 |
Why?
| | Cytoskeleton | 2 | 2020 | 183 | 0.230 |
Why?
| | Drosophila | 2 | 2020 | 143 | 0.230 |
Why?
| | Mice, Transgenic | 5 | 2020 | 2119 | 0.230 |
Why?
| | Paranasal Sinuses | 2 | 2023 | 76 | 0.220 |
Why?
| | Cell Movement | 4 | 2020 | 945 | 0.220 |
Why?
| | Wnt4 Protein | 1 | 2023 | 19 | 0.210 |
Why?
| | Mucin 5AC | 4 | 2025 | 69 | 0.210 |
Why?
| | Cell Differentiation | 5 | 2021 | 1902 | 0.210 |
Why?
| | Primary Cell Culture | 2 | 2015 | 160 | 0.210 |
Why?
| | Fluorescent Antibody Technique | 2 | 2015 | 376 | 0.210 |
Why?
| | Membrane Proteins | 3 | 2019 | 1119 | 0.200 |
Why?
| | Picornaviridae Infections | 1 | 2023 | 45 | 0.200 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2023 | 80 | 0.200 |
Why?
| | Mucociliary Clearance | 2 | 2022 | 42 | 0.200 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2022 | 30 | 0.200 |
Why?
| | Pulmonary Surfactants | 1 | 2023 | 106 | 0.190 |
Why?
| | Aryldialkylphosphatase | 1 | 2022 | 18 | 0.190 |
Why?
| | Mutation | 6 | 2022 | 3717 | 0.190 |
Why?
| | Enoxaparin | 1 | 2022 | 59 | 0.180 |
Why?
| | Cysts | 1 | 2022 | 109 | 0.180 |
Why?
| | Pulmonary Fibrosis | 1 | 2025 | 386 | 0.180 |
Why?
| | Interferons | 1 | 2022 | 194 | 0.180 |
Why?
| | Nicotine | 1 | 2023 | 303 | 0.180 |
Why?
| | Bacteriophages | 1 | 2022 | 93 | 0.170 |
Why?
| | Mycobacterium abscessus | 1 | 2022 | 107 | 0.170 |
Why?
| | Skin Neoplasms | 2 | 2020 | 825 | 0.170 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2020 | 8 | 0.170 |
Why?
| | Mice, Knockout | 2 | 2025 | 2871 | 0.170 |
Why?
| | Environmental Exposure | 1 | 2024 | 462 | 0.170 |
Why?
| | Antiviral Agents | 2 | 2023 | 712 | 0.160 |
Why?
| | Nasal Mucosa | 1 | 2020 | 107 | 0.160 |
Why?
| | Acute Lung Injury | 1 | 2022 | 279 | 0.160 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5440 | 0.160 |
Why?
| | Chronic Disease | 5 | 2023 | 1720 | 0.150 |
Why?
| | Cyclin A1 | 1 | 2018 | 5 | 0.150 |
Why?
| | Cyclin E | 1 | 2018 | 23 | 0.150 |
Why?
| | Mammary Glands, Animal | 1 | 2019 | 124 | 0.150 |
Why?
| | Particulate Matter | 1 | 2020 | 246 | 0.150 |
Why?
| | Cadherins | 1 | 2019 | 188 | 0.140 |
Why?
| | Cells, Cultured | 4 | 2020 | 4083 | 0.140 |
Why?
| | Cell Nucleus | 2 | 2018 | 582 | 0.140 |
Why?
| | Mitosis | 1 | 2018 | 180 | 0.140 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2015 | 146 | 0.140 |
Why?
| | Purines | 1 | 2018 | 172 | 0.140 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2022 | 352 | 0.140 |
Why?
| | Pneumonia | 1 | 2022 | 616 | 0.130 |
Why?
| | Mucin-5B | 3 | 2025 | 217 | 0.130 |
Why?
| | Kidney Tubules | 1 | 2017 | 114 | 0.130 |
Why?
| | Polycystic Kidney Diseases | 1 | 2017 | 68 | 0.130 |
Why?
| | Nasal Polyps | 1 | 2017 | 59 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1706 | 0.130 |
Why?
| | Xenopus laevis | 3 | 2013 | 99 | 0.120 |
Why?
| | Nevus, Pigmented | 1 | 2015 | 32 | 0.120 |
Why?
| | Up-Regulation | 1 | 2018 | 840 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 570 | 0.120 |
Why?
| | Tissue Fixation | 1 | 2015 | 34 | 0.120 |
Why?
| | Staining and Labeling | 1 | 2015 | 141 | 0.110 |
Why?
| | Pericytes | 1 | 2014 | 28 | 0.110 |
Why?
| | Body Patterning | 2 | 2019 | 127 | 0.110 |
Why?
| | Single-Cell Analysis | 3 | 2022 | 277 | 0.110 |
Why?
| | NIH 3T3 Cells | 2 | 2020 | 141 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-myb | 1 | 2013 | 10 | 0.110 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1181 | 0.100 |
Why?
| | Melanoma | 1 | 2020 | 730 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1501 | 0.100 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 185 | 0.100 |
Why?
| | Microscopy, Electron | 1 | 2013 | 426 | 0.100 |
Why?
| | Female | 12 | 2024 | 68776 | 0.100 |
Why?
| | Embryo, Nonmammalian | 2 | 2012 | 166 | 0.100 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4063 | 0.090 |
Why?
| | Models, Biological | 2 | 2009 | 1722 | 0.090 |
Why?
| | Carrier Proteins | 1 | 2015 | 743 | 0.090 |
Why?
| | Pregnancy | 1 | 2023 | 6402 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2282 | 0.090 |
Why?
| | Inflammation | 4 | 2022 | 2736 | 0.080 |
Why?
| | Green Fluorescent Proteins | 2 | 2012 | 385 | 0.080 |
Why?
| | Aminophenols | 2 | 2022 | 144 | 0.080 |
Why?
| | Myoclonic Epilepsies, Progressive | 1 | 2008 | 1 | 0.080 |
Why?
| | Rho Factor | 1 | 2008 | 3 | 0.080 |
Why?
| | Dishevelled Proteins | 1 | 2008 | 3 | 0.080 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 429 | 0.080 |
Why?
| | Obesity | 1 | 2022 | 2883 | 0.080 |
Why?
| | Ataxia | 1 | 2008 | 42 | 0.080 |
Why?
| | Male | 12 | 2024 | 63681 | 0.070 |
Why?
| | Homozygote | 1 | 2008 | 193 | 0.070 |
Why?
| | Adult | 8 | 2023 | 35576 | 0.070 |
Why?
| | Cell Division | 1 | 2009 | 797 | 0.070 |
Why?
| | Lentivirus Infections | 1 | 2007 | 7 | 0.070 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2007 | 48 | 0.070 |
Why?
| | Lentivirus | 1 | 2007 | 53 | 0.070 |
Why?
| | Crosses, Genetic | 1 | 2007 | 142 | 0.070 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2019 | 331 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 207 | 0.070 |
Why?
| | Mice, Inbred C3H | 1 | 2007 | 273 | 0.070 |
Why?
| | Transduction, Genetic | 1 | 2007 | 128 | 0.070 |
Why?
| | Proteins | 1 | 2012 | 942 | 0.070 |
Why?
| | Models, Genetic | 1 | 2009 | 594 | 0.070 |
Why?
| | Quality of Life | 3 | 2023 | 2704 | 0.070 |
Why?
| | Actins | 1 | 2008 | 411 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2019 | 315 | 0.060 |
Why?
| | Middle Aged | 7 | 2024 | 31154 | 0.060 |
Why?
| | Machine Learning | 2 | 2020 | 443 | 0.060 |
Why?
| | Endothelial Progenitor Cells | 1 | 2025 | 20 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2022 | 697 | 0.060 |
Why?
| | Glycosylation | 1 | 2025 | 150 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2024 | 4897 | 0.060 |
Why?
| | Microvessels | 1 | 2025 | 83 | 0.060 |
Why?
| | Mutagens | 1 | 2004 | 17 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2004 | 63 | 0.050 |
Why?
| | Phosphofructokinase-2 | 1 | 2022 | 15 | 0.050 |
Why?
| | Chloride Channel Agonists | 1 | 2023 | 77 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1894 | 0.050 |
Why?
| | Rhinovirus | 1 | 2023 | 56 | 0.050 |
Why?
| | Quercetin | 1 | 2022 | 11 | 0.050 |
Why?
| | Drosophila melanogaster | 1 | 2004 | 215 | 0.050 |
Why?
| | Cell Line | 1 | 2007 | 2781 | 0.050 |
Why?
| | Serine Endopeptidases | 1 | 2022 | 118 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2535 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 108 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 188 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 390 | 0.040 |
Why?
| | Bleomycin | 1 | 2022 | 244 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 274 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2022 | 216 | 0.040 |
Why?
| | Alleles | 2 | 2019 | 845 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2022 | 318 | 0.040 |
Why?
| | Amino Acid Sequence | 3 | 2012 | 2058 | 0.040 |
Why?
| | Comparative Genomic Hybridization | 1 | 2020 | 32 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2022 | 265 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 109 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2020 | 114 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 2012 | 2832 | 0.040 |
Why?
| | Fibroblasts | 1 | 2025 | 948 | 0.040 |
Why?
| | Prospective Studies | 2 | 2022 | 7133 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2024 | 10230 | 0.040 |
Why?
| | Smokers | 1 | 2020 | 138 | 0.040 |
Why?
| | Loss of Function Mutation | 1 | 2019 | 39 | 0.040 |
Why?
| | Cadherin Related Proteins | 1 | 2019 | 12 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 625 | 0.040 |
Why?
| | Child | 4 | 2020 | 20883 | 0.040 |
Why?
| | Health Status | 1 | 2023 | 755 | 0.040 |
Why?
| | Embryonic Development | 1 | 2019 | 114 | 0.040 |
Why?
| | Enterovirus | 1 | 2019 | 78 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 373 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 284 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2012 | 372 | 0.040 |
Why?
| | Air Pollution | 1 | 2020 | 217 | 0.040 |
Why?
| | Turbinates | 1 | 2017 | 16 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2019 | 317 | 0.030 |
Why?
| | Computer Systems | 1 | 2017 | 44 | 0.030 |
Why?
| | Aged | 3 | 2024 | 22103 | 0.030 |
Why?
| | Air Pollutants | 1 | 2020 | 312 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2025 | 2548 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1434 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1269 | 0.030 |
Why?
| | Child, Preschool | 2 | 2020 | 10517 | 0.030 |
Why?
| | Adolescent | 3 | 2020 | 20393 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 887 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2017 | 769 | 0.030 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2014 | 23 | 0.030 |
Why?
| | Magnetics | 1 | 2014 | 44 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1952 | 0.030 |
Why?
| | Microcirculation | 1 | 2014 | 145 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2014 | 226 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 505 | 0.030 |
Why?
| | Ependyma | 1 | 2013 | 4 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1839 | 0.030 |
Why?
| | Mice, SCID | 1 | 2014 | 351 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1333 | 0.030 |
Why?
| | Xenopus | 1 | 2013 | 86 | 0.030 |
Why?
| | Young Adult | 2 | 2020 | 12426 | 0.030 |
Why?
| | Time Factors | 1 | 2024 | 6556 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2391 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 587 | 0.020 |
Why?
| | Transcription Factors | 1 | 2020 | 1651 | 0.020 |
Why?
| | Algorithms | 1 | 2020 | 1622 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1717 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2013 | 220 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2019 | 2708 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2012 | 295 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2073 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2012 | 229 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3076 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 3973 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2014 | 847 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 400 | 0.020 |
Why?
| | Aging | 1 | 2020 | 1776 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 958 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3083 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2014 | 749 | 0.020 |
Why?
| | Cytokines | 1 | 2017 | 2017 | 0.020 |
Why?
| | Physical Chromosome Mapping | 1 | 2008 | 17 | 0.020 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2008 | 21 | 0.020 |
Why?
| | LIM Domain Proteins | 1 | 2008 | 17 | 0.020 |
Why?
| | Consanguinity | 1 | 2008 | 47 | 0.020 |
Why?
| | Genes, Recessive | 1 | 2008 | 76 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7086 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2008 | 164 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 341 | 0.020 |
Why?
| | Genetic Markers | 1 | 2008 | 338 | 0.020 |
Why?
| | Pedigree | 1 | 2008 | 487 | 0.020 |
Why?
| | Skin | 1 | 2012 | 725 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 475 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 821 | 0.020 |
Why?
| | Nondisjunction, Genetic | 1 | 2004 | 3 | 0.010 |
Why?
| | Methyl Methanesulfonate | 1 | 2004 | 6 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 2004 | 63 | 0.010 |
Why?
| | Kidney | 1 | 2012 | 1385 | 0.010 |
Why?
| | Meiosis | 1 | 2004 | 64 | 0.010 |
Why?
| | Mechlorethamine | 1 | 2004 | 63 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2004 | 190 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2004 | 504 | 0.010 |
Why?
| | DNA Repair | 1 | 2004 | 207 | 0.010 |
Why?
| | Brain | 1 | 2013 | 2679 | 0.010 |
Why?
| | Base Sequence | 1 | 2004 | 2142 | 0.010 |
Why?
| | Saccharomyces cerevisiae | 1 | 2004 | 532 | 0.010 |
Why?
| | DNA | 1 | 2004 | 1400 | 0.010 |
Why?
|
|
Vladar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|